E-MAIL: [email protected]
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
102025.12
FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome
082025.12
FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US
282025.11
Xinfuda Introduces Its Next-Generation Injection Pen: Precision and Comfort in Patient Care
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
Reserved Powered by
MAKE AN ENQUIRY